Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling

被引:87
作者
Ho, JMY
Beattie, BK
Squire, JA
Frank, DA
Barber, DL
机构
[1] Ontario Canc Inst, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada
[2] Toronto Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V93.12.4354.412k30_4354_4364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To study constitutive Janus kinase signaling, chimeric proteins were generated between the pointed domain of the ets transcription factor TEL and the cytosolic tyrosine kinase Jak2. The effects of these proteins on interleukin-3 (IL-3)-dependent proliferation of the hematopoietic cell line, Ba/F3, were studied, Fusion of TEL to the functional kinase (JH1) domain of Jak2 resulted in conversion of Ba/F3 cells to factor-independence. Importantly, fusion of TEL to the Jak2 pseudokinase (JH2) domain or a kinase-inactive Jak2 JH1 domain had no effect on IL-3-dependent proliferation of Ba/F3 cells. Active TEL-Jak2 constructs (consisting of either Jak2 JH1 or Jak2 JH2+JH1 domain fusions) were constitutively tyrosine-phosphorylated but did not affect phosphorylation of endogeneous Jak1, Jak2, or Jak3. TEL-Jak2 activation resulted in the constitutive tyrosine phosphorylation of Stat1, Stat3, and Stat5 as determined by detection of phosphorylation using activation-specific antibodies and by binding of each protein to a preferential GAS sequence in electrophoretic mobility shift assays. Elucidation of signaling events downstream of TEL Jak2 activation may provide insight into the mechanism of leukemogenesis mediated by this oncogenic fusion protein. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4354 / 4364
页数:11
相关论文
共 64 条
[1]   Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene [J].
Ascherman, DP ;
Migone, TS ;
Friedmann, MC ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8704-8709
[2]   INTERLEUKIN-3 SIGNALS THROUGH MULTIPLE ISOFORMS OF STAT5 [J].
AZAM, M ;
ERDJUMENTBROMAGE, H ;
KREIDER, BL ;
XIA, M ;
QUELLE, F ;
BASU, R ;
SARIS, C ;
TEMPST, P ;
IHLE, JN ;
SCHINDLER, C .
EMBO JOURNAL, 1995, 14 (07) :1402-1411
[3]   ERYTHROPOIETIN AND INTERLEUKIN-2 ACTIVATE DISTINCT JAK KINASE FAMILY MEMBERS [J].
BARBER, DL ;
DANDREA, AD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6506-6514
[4]   Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway [J].
Bonni, A ;
Sun, Y ;
NadalVicens, M ;
Bhatt, A ;
Frank, DA ;
Rozovsky, I ;
Stahl, N ;
Yancopoulos, GD ;
Greenberg, ME .
SCIENCE, 1997, 278 (5337) :477-483
[5]   Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl [J].
Carlesso, N ;
Frank, DA ;
Griffin, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :811-820
[6]   The TEL platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways [J].
Carroll, M ;
Tomasson, MH ;
Barker, GF ;
Golub, TR ;
Gilliland, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14845-14850
[7]  
Chai SK, 1997, J IMMUNOL, V159, P4720
[8]   TYROSINE-343 IN THE ERYTHROPOIETIN RECEPTOR POSITIVELY REGULATES ERYTHROPOIETIN-INDUCED CELL-PROLIFERATION AND STAT5 ACTIVATION [J].
DAMEN, JE ;
WAKAO, H ;
MIYAJIMA, A ;
KROSL, J ;
HUMPHRIES, RK ;
CUTLER, RL ;
KRYSTAL, G .
EMBO JOURNAL, 1995, 14 (22) :5557-5568
[9]   Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 [J].
DaSilva, L ;
Rui, H ;
Erwin, RA ;
Howard, OMZ ;
Kirken, RA ;
Malabarba, MG ;
Hackett, RH ;
Larner, AC ;
Farrar, WL .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 117 (02) :131-140
[10]   Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) [J].
Eguchi, M ;
Eguchi-Ishimae, M ;
Tojo, A ;
Morishita, K ;
Suzuki, K ;
Sato, Y ;
Kudoh, S ;
Tanaka, K ;
Setoyama, M ;
Nagamura, F ;
Asano, S ;
Kamada, N .
BLOOD, 1999, 93 (04) :1355-1363